STAAR Surgical Company [NASDAQ: STAA] traded at a low on 05/04/21, posting a -12.19 loss after which it closed the day’ session at $122.00. The company report on April 21, 2021 that STAAR Surgical to Report First Quarter Results on May 5, 2021.
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced that it will release financial results for the first quarter ended April 2, 2021 on Wednesday, May 5, 2021 after the market close.
STAAR will host a conference call and webcast on Wednesday, May 5 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operational progress. To access the conference call (Conference ID 4495547), please dial 833-350-1429 for domestic participants and 647-689-6661 for international participants. The live webcast can be accessed from the investor relations section of the STAAR website at www.staar.com.
The results of the trading session contributed to over 1384347 shares changing hands. Over the past one week, the price volatility of STAAR Surgical Company stands at 5.47% while the volatility over the past one month is 4.46%.
The market cap for STAA stock reached $5.77 billion, with 46.24 million shares outstanding and 45.57 million shares in the current float. Compared to the average trading volume of 559.02K shares, STAA reached a trading volume of 1384347 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about STAAR Surgical Company [STAA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for STAA shares is $119.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on STAA stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Benchmark Company have made an estimate for STAAR Surgical Company shares, keeping their opinion on the stock as Hold, with their previous recommendation back on January 19, 2021. The new note on the price target was released on October 26, 2020, representing the official price target for STAAR Surgical Company stock. Previously, the target price had yet another raise to $58, while Sidoti analysts kept a Buy rating on STAA stock. On August 06, 2020, analysts increased their price target for STAA shares from 50 to 66.
The Average True Range (ATR) for STAAR Surgical Company is set at 5.83, with the Price to Sales ratio for STAA stock in the period of the last 12 months amounting to 35.29. The Price to Book ratio for the last quarter was 28.57, with the Price to Cash per share for the same quarter was set at 3.22. Price to Free Cash Flow for STAA in the course of the last twelve months was 457.98 with Quick ratio for the last quarter at 4.80.
How has STAA stock performed recently?
STAAR Surgical Company [STAA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -10.38. With this latest performance, STAA shares gained by 14.47% in over the last four-week period, additionally plugging by 68.28% over the last 6 months – not to mention a rise of 234.71% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for STAA stock in for the last two-week period is set at 49.96, with the RSI for the last a single of trading hit 41.71, and the three-weeks RSI is set at 53.58 for STAAR Surgical Company [STAA]. The present Moving Average for the last 50 days of trading for this stock 108.87, while it was recorded at 134.85 for the last single week of trading, and 81.83 for the last 200 days.
STAAR Surgical Company [STAA]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and STAAR Surgical Company [STAA] shares currently have an operating margin of +4.88 and a Gross Margin at +73.14. STAAR Surgical Company’s Net Margin is presently recorded at +3.62.
Return on Total Capital for STAA is now 4.22, given the latest momentum, and Return on Invested Capital for the company is 3.21. Return on Equity for this stock inclined to 3.31, with Return on Assets sitting at 2.55. When it comes to the capital structure of this company, STAAR Surgical Company [STAA] has a Total Debt to Total Equity ratio set at 5.48. Additionally, STAA Total Debt to Total Capital is recorded at 5.19, with Total Debt to Total Assets ending up at 4.20. Long-Term Debt to Equity for the company is recorded at 3.33, with the Long-Term Debt to Total Capital now at 3.16.
Reflecting on the efficiency of the workforce at the company, STAAR Surgical Company [STAA] managed to generate an average of $10,283 per employee. Receivables Turnover for the company is 4.58 with a Total Asset Turnover recorded at a value of 0.70.STAAR Surgical Company’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.80 and a Current Ratio set at 5.20.
Earnings analysis for STAAR Surgical Company [STAA]
With the latest financial reports released by the company, STAAR Surgical Company posted 0/share EPS, while the average EPS was predicted by analysts to be reported at -0.04/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 100.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for STAA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for STAAR Surgical Company go to 30.00%.
Insider trade positions for STAAR Surgical Company [STAA]
There are presently around $5,520 million, or 90.60% of STAA stock, in the hands of institutional investors. The top three institutional holders of STAA stocks are: BROADWOOD CAPITAL INC with ownership of 10,795,348, which is approximately 0% of the company’s market cap and around 0.80% of the total institutional ownership; VANGUARD GROUP INC, holding 4,195,242 shares of the stock with an approximate value of $582.89 million in STAA stocks shares; and BLACKROCK INC., currently with $488.42 million in STAA stock with ownership of nearly 5.128% of the company’s market capitalization.
Positions in STAAR Surgical Company stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 107 institutional holders increased their position in STAAR Surgical Company [NASDAQ:STAA] by around 3,409,849 shares. Additionally, 91 investors decreased positions by around 3,018,946 shares, while 27 investors held positions by with 33,303,662 shares. The mentioned changes placed institutional holdings at 39,732,457 shares, according to the latest SEC report filing. STAA stock had 43 new institutional investments in for a total of 1,184,669 shares, while 19 institutional investors sold positions of 1,340,665 shares during the same period.